The Times They Are A-Changin’: Opportunities In Medtech Regulation For The UK After Brexit
A legal expert’s view of medical device regulation in the UK in 2021
Executive Summary
The end of a calendar year is a chance to reflect on times past and the future, to make resolutions and look ahead to changes for the better. With Brexit in mind, the turn of 2020 is a time to prophesize on UK medtech’s immediate future.
You may also be interested in...
Global Medtech Guidance Tracker: December 2020
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Sixty-seven guidance documents have been posted on the tracker since its last update.
The Times They Are A-Changin’: Opportunities In Medtech Regulation For The UK After Brexit
The turn of the year is a chance to reflect on times past and the future, to make resolutions and look ahead to changes for the better. With Brexit in mind, this is the time to prophesize on UK medtech’s immediate future.
Entry into force of UK Bribery Act in sight
Guidance on this important piece of legislation has now been published and the law is set to enter into force in July. Alison Dennis looks at whether the guidance is helpful for medtech companies.